Jericho Chambers

An Interview with Andrew Edgecliffe-Johnson, US Business Editor at the Financial Times

This latest conversation is part of Jericho’s work to launch a new Business and Democracy Commission in 2023. We will ask difficult questions, break new ground, explore whether there is a new consensus and set out practical steps for a more effective corporate and business role in this fast-changing democratic and political context. Please do get ...

The British Government couldn’t have made its intent more clear – it’s grow or bust. But are the measures suggested to pep up the UK economy a fairy tale or genuinely sound ideas stymied by a coalition of antis?

With the exception of Extinction Rebellion (and who has heard much about them recently), most of us approve of growth. Of our salaries, our businesses, our GDP – an increase in these is said to lead to growth of our collecti...

If you want to understand this incredible geopolitical moment then Helen Thompson, Professor of Political Economy, is your person. Steeped in the history of how global energy interests and finance policy have interacted to shape the 21st century – not least in Ukraine – Helen offers an unrivalled analysis of the times we live in.

Helen has been at Cambridge since 1994. Her current research concentrates on the political economy of en...

As glaciers melt and dodgy peddlers of cryptocurrency go bust, we hear a lot about the “E” and “G” in ESG but rarely the “S” which is the essential jam in the sandwich. It’s the stranded middle child. Even classifying exactly what it means is complicated and open to widely differing interpretations. And even when benchmarks are created, how on earth do you measure it?

This podcast is about what the “S” means for employees especially...

The first Jericho Conversation of 2022 took place on April 21st. We were joined by Bill Browder, New York Times Bestseller and the founder and CEO of Hermitage Capital Management, which was the investment adviser to the largest foreign investment fund in Russia until 2005 when Bill was denied entry to the country and declared a “threat to national security” as a result of his battle against corporate corruption.

In 2018 Bill joined ...

Post-Covid what does the future of healthcare look like?

Nick Moore is the Managing Director, Biopharma, Healthcare, Stifel and has more than 20 years’ experience in the Healthcare industry. He trained originally as a medical doctor at Cambridge University and Harvard Medical School. 

In December 2013, Nicholas was named as one of the Top 40 Under 40 Rising Stars in Investment Banking by Financial News, partly in recognition of the m...

How do we ensure the nexus of technology, common sense and wellbeing to target today's challenges of an ageing population, chronic illness, mental health, loneliness and isolation? How do we spend health money better and more intelligently? When it comes to increasingly complex diagnostics what's the best way to the most positive outcomes? What about getting less ill in the first place? 

This podcast interviews five individu...